Aizant Drug Research Solutions Pvt Ltd

Aizant Drug Research Solutions Pvt Ltd Founded in 2008, Aizant Drug Research Solutions Pvt. Ltd.

has trusted as a global leader in Contract Development and Manufacturing (CDMO), Contract Manufacturing (CMO), Research & Development (R&D), and Clinical Research services.

We are proud to announce the launch of Aizant’s Dapagliflozin Tablets, 5 mg and 10 mg, in the United States, with day 1 ...
10/04/2026

We are proud to announce the launch of Aizant’s Dapagliflozin Tablets, 5 mg and 10 mg, in the United States, with day 1 market entry in collaboration with our valued partner.

This achievement underscores our continued commitment to delivering high-quality, accessible treatment options for Type 2 diabetes, backed by robust development, regulatory, and manufacturing capabilities.

This milestone highlights our focus on enabling timely market access and strengthening our presence in the global generics landscape.

Learn more: www.aizant.com

We’re excited to welcome J. Syam Sunder Kumar to the Aizant team as Head – CDMO.He brings over 30 years of experience in...
09/04/2026

We’re excited to welcome J. Syam Sunder Kumar to the Aizant team as Head – CDMO.

He brings over 30 years of experience in the pharmaceutical industry, with extensive expertise across discovery, APIs, intermediates, and a wide range of finished dosage forms. His functional expertise spans business development, global supply chain management, CRAMS, project management etc.

He has led large-scale supply chain operations, driven S&OP initiatives, and enabled operational and business transformations across leading pharmaceutical organizations.

His strong expertise in operations, supply chain strategy, and ex*****on makes him a valuable addition to our leadership team as we continue to strengthen our integrated CDMO capabilities.

We are proud to share a significant milestone with the final approval of Aizant’s Dapagliflozin Tablets, 5 mg and 10 mg ...
07/04/2026

We are proud to share a significant milestone with the final approval of Aizant’s Dapagliflozin Tablets, 5 mg and 10 mg in the United States through the ANDA pathway.

The journey of a Dapagliflozin began with a clear purpose to support the management of type 2 diabetes, where bringing such therapies forward, requires more than development alone and calls for alignment across scientific, clinical, and manufacturing capabilities.

Approvals like these are not just regulatory outcomes but reflect how effectively drug development, clinical research, and manufacturing are aligned within a unified framework as pharmaceutical development continues to grow more complex.

This milestone also reflects the dedication and collective effort of our teams across functions.

At Aizant, this integrated approach continues to shape how we support development programs from concept to commercialization.

www.aizant.com | bd@aizant.com

Behind every treatment is a journey shaped by research, careful development, and a commitment to quality at every stage....
07/04/2026

Behind every treatment is a journey shaped by research, careful development, and a commitment to quality at every stage. As therapies become more complex, the focus on safety, consistency, and regulatory alignment becomes even more critical.

This year’s theme, “Together for Health. Stand with Science,” highlights the importance of collective effort and scientific integrity in improving global health outcomes.

Each stage in this journey plays a vital role in ensuring therapies are safe, effective, and reliable.

At Aizant, we are committed to supporting this journey through responsible drug development, enabling quality-driven solutions that contribute to better health outcomes worldwide.

www.aizant.com

Wishing everyone a season filled with peace, positivity, and renewed hope.May this time inspire fresh perspectives, mean...
05/04/2026

Wishing everyone a season filled with peace, positivity, and renewed hope.

May this time inspire fresh perspectives, meaningful progress, and new beginnings in both personal and professional journeys.

On this Good Friday, we take a moment to reflect on the values of sacrifice, compassion, and hope.These timeless princip...
03/04/2026

On this Good Friday, we take a moment to reflect on the values of sacrifice, compassion, and hope.

These timeless principles continue to inspire meaningful actions, stronger connections, and a deeper sense of purpose in everything we do.

Wishing everyone a peaceful and reflective Good Friday.

Formulating complexity is often where the real challenge in drug development begins.As molecules become more complex, fo...
01/04/2026

Formulating complexity is often where the real challenge in drug development begins.

As molecules become more complex, formulation strategies play a critical role in enabling stability, bioavailability, and manufacturability. Without the right approach, these challenges can lead to delays, variability, and increased development risk.

What is increasingly clear across the industry is the need for integrated capabilities that connect formulation development with analytical insight and manufacturing. This alignment helps simplify development pathways, improve predictability, and support efficient scale-up.

At Aizant, our CDMO capabilities are designed to address complex formulation challenges, enabling smoother progression from early development to scalable manufacturing.

If you are working on complex molecules and looking for a partner to simplify your development journey, we would be glad to connect.
bd@aizant.com | www.aizant.com

On World Bipolar Day, we recognize the importance of raising awareness and fostering understanding around bipolar disord...
30/03/2026

On World Bipolar Day, we recognize the importance of raising awareness and fostering understanding around bipolar disorder and mental health.

At Aizant, we are committed to enabling progress in treatment development through our integrated CDMO capabilities across development, clinical research, and manufacturing. This seamless approach supports the journey of bringing meaningful therapies closer to patients.

Together, through awareness and innovation, we move towards better care and improved lives.

Connect with us to explore how we can support your development and manufacturing needs.
bd@aizant.com | www.aizant.com

On this auspicious day of Ram Navami, we reflect on the values of integrity, purpose, and progress that continue to shap...
27/03/2026

On this auspicious day of Ram Navami, we reflect on the values of integrity, purpose, and progress that continue to shape meaningful journeys.
Wishing you peace, prosperity, and continued growth.

Happy Ram Navami

On World Tuberculosis Day, we recognize the ongoing need to advance drug development in addressing complex global health...
24/03/2026

On World Tuberculosis Day, we recognize the ongoing need to advance drug development in addressing complex global health challenges like tuberculosis.

Developing effective, scalable, and accessible treatments requires a seamless integration of development, clinical research, and manufacturing capabilities.

At Aizant, our integrated approach supports the journey from development to commercialization, enabling progress toward better treatment outcomes and improved patient lives.

Connect with us to explore how we can support your development and manufacturing needs.
bd@aizant.com | www.aizant.com

Oncology drug development demands precision, specialized expertise, and the ability to manage complexity across every st...
23/03/2026

Oncology drug development demands precision, specialized expertise, and the ability to manage complexity across every stage.

At Aizant, our CDMO services are supported by dedicated oncology capabilities designed to handle complex programs from development through manufacturing. By integrating development, analytical, and manufacturing functions within a single ecosystem, we enable greater control, consistency, and efficiency across the product lifecycle.

Explore how we support oncology development: www.aizant.com | bd@aizant.com

Address

Sy. No. 172 & 173, Quthbullapur Mandal, Apparel Park Road, Dulapally
Hyderabad
500100

Opening Hours

Monday 9am - 6pm
Tuesday 9am - 6pm
Wednesday 9am - 6pm
Thursday 9am - 6pm
Friday 9am - 6pm

Website

Alerts

Be the first to know and let us send you an email when Aizant Drug Research Solutions Pvt Ltd posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Shortcuts

Share

Category